Healthcare-focused investment firm OrbiMed Asia Partners has led a US$19 million series B round of financing in InventisBio, a biotech company dedicated to the discovery and development of novel medicines.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
